JZP-361

Overview

JZP-361 is a potent, reversible and selective inhibitor of human recombinant MAGL (hMAGL) with an IC 50 of 46 nM. JZP-361 also shows antihistaminergic activities and can be used for asthma research.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Parkinson's Disease | Products > Disease Areas > Obesity | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > MAGL | Products > Signaling Pathways > Histamine Receptor

Product Information

• Catalog No.: HY-121422
• CAS No.: 1680193-80-9
• Molecular Formula: C22H20ClN5O
• Molecular Weight: 405.88
• Purity: 99.63%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source